Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
31 Jul 2019 Immunogenicity Prediction in BRCA Deficient Breast Cancer Breast cancer - Cancer Immunology and Immunotherapy
30 Jul 2019 New Guidance Documents Lay Foundations in Reporting on Medicines Shortages in the EU Bioethics, legal and economic issues
30 Jul 2019 EMA Recommends Extension of Indications for Trifluridine/Tipiracil Gastrointestinal cancers - Anticancer agents & Biologic therapy
29 Jul 2019 EMA Recommends Extension of Indications for Atezolizumab Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
26 Jul 2019 EMA Recommends Granting a Conditional Marketing Authorisation for Larotrectinib Personalised medicine - Anticancer agents & Biologic therapy
25 Jul 2019 Updated PORTEC-3 Analysis Shows Improved Survival With Chemoradiotherapy Versus Radiotherapy Alone Gynaecologic malignancies - Anticancer agents & Biologic therapy
24 Jul 2019 Unfavourable Benefit-Risk Profile of Pembrolizumab Plus Pomalidomide and Dexamethasone in Multiple Myeloma Haematologic malignancies - Cancer Immunology and Immunotherapy
23 Jul 2019 EMA Starts Re-examination of Negative Opinion for Glutamine Haematologic malignancies
22 Jul 2019 Towards Lung Cancer Precision Prevention in Chinese Populations Translational research - Epidemiology/Etiology/Cancer Prevention
19 Jul 2019 Discovery of Novel Susceptibility Loci and Genes for Prostate Cancer Risk Genitourinary cancers - Translational research - Epidemiology/Etiology/Cancer Prevention
17 Jul 2019 The Establishment of Pan-Africa's First Biobank Personalised medicine
16 Jul 2019 EMA Starts Review of Meningioma Risk With Cyproterone Medicines Genitourinary cancers - Central nervous system malignancies - Anticancer agents & Biologic therapy
15 Jul 2019 Recombinant Zoster Vaccine Reduces the Incidence of Herpes Zoster After Autologous HSCT Haematologic malignancies
12 Jul 2019 FDA Grants Accelerated Approval to Selinexor for Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
11 Jul 2019 Paraneoplastic Encephalitis in Testicular Cancer Genitourinary cancers